Acular patent ruling
Executive Summary
Federal appeals court rules in favor of Apotex in litigation over a patent covering Allergan's Acular (ketorolac ophthalmic solution). The appeals court on May 18 remanded the case to San Francisco federal court for further consideration on obviousness claims. In January 2004, the California court ruled that Allergan/Syntex' patent was valid and Apotex' ANDA infringed (1"The Pink Sheet" Jan. 19, 2004, In Brief)...